📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-01 19:29
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
33 announcements match the current filters (relevance ≥ 5).
Maharashtra GST Officials Initiate Search at Sudarshan Chemical Offices and Units
Sudarshan Chemical Industries reported that the Deputy Commissioner of State Tax, Maharashtra State, Mumbai initiated inspection and search proceedings on October 1, 2026. The search was conducted under Section 67 of the Maharashtra Goods and Services Tax Act, 2017, across select offices and manufacturing facilities in Maharashtra. The company stated that no specific violations or allegations have been communicated yet. As of the filing date, management reports no material impact on its operations or financial performance.
Confidence: HIGH
What changedState GST authorities initiated a formal search and inspection operation at Sudarshan Chemical's Maharashtra premises on October 1, 2026.
Why it mattersGST inspections under Section 67 can lead to scrutiny of input tax credits, revenue recognition, or tax assessments, posing potential financial liability once concluding reports are issued.
Date of inspection initiation: 1st October, 2026Section of MGST Act: Section 67Quantified financial impact: not disclosed
📅 Short termMay create short-term stock overhang as market participants await clarity on whether any tax demand or penalty will arise.
📈 Long termStructural impact depends on whether findings indicate procedural mismatches or substantial recurring tax liabilities.
⚠ Risk flags
- Potential tax demand or penalties post-inspection
- Unquantified regulatory exposure
Key Highlights
Inspection/search initiated on October 1, 2026 under Section 67 of the Maharashtra GST Act, 2017
Action carried out by the Deputy Commissioner of State Tax, Maharashtra State, Mumbai
Proceedings cover select offices and manufacturing units located in Maharashtra
No contraventions or monetary demands communicated by the authorities as of October 1, 2026
👀 What to Watch
Monitor subsequent regulatory disclosures for any tax demand notices, penalties, or formal findings resulting from the inspection.
Sudarshan Chemical Acquires 15.89% in Sudarshan Colorants for ₹150.76 Cr
Sudarshan Chemical Industries Limited has acquired a 15.89% stake (36,68,036 equity shares) in step-down subsidiary Sudarshan Colorants India Limited from its wholly owned subsidiary Sudarshan Europe B.V. for ₹150.76 crore. This forms part of an overarching internal restructuring plan announced in August 2026 to directly consolidate 70.26% of Sudarshan Colorants (formerly Heubach Colorants India). The transaction consideration represents ~1.5% of Sudarshan Chemical's TTM revenue of ₹9,922 crore and ~5.9% of its net worth. Being an intra-group share transfer, it streamlines ownership without altering overall consolidated economic interest.
Confidence: HIGH
What changedSudarshan Chemical directly acquired a 15.89% stake in Sudarshan Colorants India Limited from its wholly owned subsidiary Sudarshan Europe B.V. on 1st October 2026.
Why it mattersSimplifies group corporate structure following the Heubach acquisition, transitioning ownership of the Indian operating entity directly to the parent company.
Acquisition consideration: ₹150,75,62,796Shares acquired: 36,68,036 equity sharesStake acquired: 15.89%Target stake under proposal: 70.26%Deal value vs Net Worth: ~5.9%
📅 Short termNeutral operational impact as this is an internal re-alignment among group entities and does not bring incremental third-party cash flows.
📈 Long termAids corporate governance and operational efficiency by directly holding key Indian operating assets instead of routing through European holding entities.
⚠ Risk flags
- Internal cash reallocation across subsidiaries
- Related-party transaction execution
Key Highlights
Completed acquisition of 36,68,036 equity shares of face value ₹10.00 each
Acquired stake represents 15.89% of the total share capital of Sudarshan Colorants India Limited
Aggregate cash consideration paid is ₹150,75,62,796 (~₹150.76 crore)
Part of a broader proposal to acquire up to 70.26% shareholding from overseas subsidiaries
👀 What to Watch
Track subsequent filings regarding the acquisition of the remaining portion of the planned 70.26% stake from Swiss step-down subsidiaries.
Sudarshan Chemical Signs SPA to Acquire 15.89% in Sudarshan Colorants for ₹150.76 Cr
Sudarshan Chemical Industries has executed a share purchase agreement dated September 28, 2026, to acquire a 15.89% stake (36,68,036 shares) in Sudarshan Colorants India Limited (formerly Heubach Colorants India Limited) from its wholly owned subsidiary, Sudarshan Europe B.V. The transaction consideration is ₹150.76 crore, with completion scheduled on or after September 29, 2026. This transaction is part of a broader proposal disclosed on August 12, 2026, to acquire a 70.26% total stake in the target company from European subsidiaries.
Confidence: HIGH
What changedSudarshan Chemical executed an SPA to directly acquire 15.89% of Sudarshan Colorants India from its European subsidiary for ₹150.76 crore.
Why it mattersThis represents an internal group restructuring step to bring shareholding in the Indian operating entity directly under the Indian parent following the global Heubach acquisition.
Acquisition Value: INR 150,75,62,796Equity Stake Acquired: 15.89%Number of Shares: 36,68,036Total Planned Stake: 70.26%Deal Value vs Net Worth: ~5.95%
📅 Short termLimited market impact as this is an inter-corporate restructuring among wholly owned subsidiaries with no external cash outflow from the consolidated group.
📈 Long termSimplifies group corporate structure, aligns ownership of Indian operations directly with the listed entity, and supports integration synergies.
⚠ Risk flags
- Related-party transaction execution risk across cross-border subsidiaries
Key Highlights
Executed Share Purchase Agreement to acquire 36,68,036 equity shares (15.89% stake) of Sudarshan Colorants India Limited
Total transaction consideration is ₹150,75,62,796 (approx. ₹150.76 crore)
Acquisition being made from wholly owned subsidiary Sudarshan Europe B.V.
Proposed to be consummated on or after 29th September 2026
Part of an ongoing plan to consolidate a 70.26% stake from European step-down subsidiaries
👀 What to Watch
Watch for subsequent filings regarding the acquisition of the remaining balance of the planned 70.26% holding and regulatory clearances for this internal group restructuring.
Sudarshan Chemical to Divest VP4 Frankfurt GmbH for EUR 76.5 Mn to Delever Balance Sheet
Sudarshan Chemical Industries has entered into a definitive Share Purchase and Transfer Agreement to divest 100% stake in its step-down subsidiary, VP4 Frankfurt GmbH, for EUR 76.5 million (~Rs 700+ crore). The VP4 facility generated FY26 revenue of EUR 15.7 million and EBITDA of EUR 4.1 million (Q1 FY27 revenue EUR 4.1 million, EBITDA EUR 1.3 million). The buyer is Celanese US Holdings LLC, with operations transitioning to Nutrinova (a Celanese-Mitsui JV). Sudarshan consumes only ~5% of VP4 output captively and has secured a long-term supply contract with Nutrinova for Diketene.
Confidence: HIGH
What changedSudarshan Chemical updated its investor presentation detailing the definitive agreement to divest VP4 Frankfurt GmbH for EUR 76.5 million.
Why it mattersMonetising non-core chemical intermediates capacity provides liquidity to prepay Heubach acquisition debt and shifts Sudarshan towards a zero net debt balance sheet.
Deal Value: EUR 76.5 MnVP4 FY26 Revenue: EUR 15.7 MnVP4 FY26 EBITDA: EUR 4.1 MnVP4 Q1 FY27 EBITDA: EUR 1.3 MnCaptive Output Used by Sudarshan: 5%Expected Deal Closure: ~ 2-3 months
📅 Short termPositive sentiment driver as the transaction monetizes non-core assets at favorable multiples and outlines a direct debt repayment path.
📈 Long termStrengthens capital structure by deleveraging acquisition debt while maintaining raw material security through long-term supply agreements.
⚠ Risk flags
- Closing conditions and regulatory approvals over the next 2-3 months
- Counterparty execution on long-term supply agreements for Diketene
Key Highlights
Deal value of EUR 76.5 Mn for 100% stake in VP4 Frankfurt GmbH, with closing expected in ~2-3 months
Proceeds to be utilized primarily for prepayment of acquisition loans, positioning the company to be zero net debt/cash positive
VP4 Frankfurt reported FY26 revenue of EUR 15.7 Mn and EBITDA of EUR 4.1 Mn (Q1 FY27 EBITDA of EUR 1.3 Mn)
Only 5% of facility output was used internally; Sudarshan secured a long-term supply agreement with Nutrinova post-sale
👀 What to Watch
Track the transaction closure timeline over the next 2-3 months and monitor subsequent debt reduction announcements in upcoming quarterly filings.
Sudarshan Chemical to Divest VP4 Frankfurt for EUR 76.5 Mn to Delever Balance Sheet
Sudarshan Chemical Industries has entered into a definitive agreement to sell 100% stake in step-down subsidiary VP4 Frankfurt GmbH to Celanese US Holdings LLC for a deal value of EUR 76.5 million. VP4 Frankfurt, which produces Diketene and CKP, generated EUR 15.7 million in revenue and EUR 4.1 million in EBITDA in FY26. Only 5% of the plant's output was used captively by Sudarshan, with 90-95% sold to Nutrinova. Management plans to use the proceeds primarily to prepay acquisition debt to become net debt free, while securing a long-term Diketene supply agreement with Nutrinova.
Confidence: HIGH
What changedSudarshan signed a definitive Share Purchase and Transfer Agreement to sell 100% of non-core subsidiary VP4 Frankfurt GmbH for EUR 76.5 million.
Why it mattersMonetizes a non-core intermediate asset to pay down acquisition-related borrowings, strengthening the balance sheet and moving the company toward zero net debt without disrupting its raw material supply.
Deal Value: EUR 76.5 MnVP4 FY26 Revenue: EUR 15.7 MnVP4 FY26 EBITDA: EUR 4.1 MnVP4 Q1FY27 Revenue: EUR 4.1 MnExpected Deal Closure: ~ 2-3 months
📅 Short termPositive sentiment driver as the monetization of non-core European assets provides substantial cash inflows to clear acquisition debt.
📈 Long termEnhances capital efficiency and sharpens strategic focus on the core global pigments portfolio post-Heubach integration.
⚠ Risk flags
- Closure is subject to customary closing conditions over the next 2-3 months
- Reliance on third-party long-term supply agreements for captive Diketene requirements
Key Highlights
Divestment of 100% stake in VP4 Frankfurt GmbH for EUR 76.5 million
VP4 delivered EUR 15.7 million revenue and EUR 4.1 million EBITDA in FY26 (EUR 4.1M revenue, EUR 1.3M EBITDA in Q1FY27)
Non-core asset: Only 5% was used for captive consumption, while 90-95% was sold to Nutrinova
Proceeds earmarked for acquisition loan prepayment to achieve zero net debt status
Transaction expected to close in approximately 2-3 months with long-term raw material supply secured
👀 What to Watch
Track the completion of the transaction within the 2-3 month timeline, receipt of EUR 76.5 million proceeds, and subsequent reduction in consolidated debt and interest expense.
Sudarshan Divests VP4 Frankfurt Subsidiary to Celanese to Focus on Core Pigments
Sudarshan Chemical Industries has announced the divestment of its step-down subsidiary, VP4 Frankfurt GmbH, to US-based Celanese Corporation. VP4 Frankfurt, which came into Sudarshan's fold via the Heubach Group acquisition, manufactures intermediates like Diketene primarily as a tolling operator for Nutrinova (a Celanese affiliate). Financial consideration and deal valuation were not disclosed in the press release. Following the transaction, Nutrinova will continue to supply Sudarshan with the intermediate materials required for its captive consumption.
Confidence: MEDIUM
What changedSudarshan Chemical agreed to sell its non-core intermediate manufacturing subsidiary VP4 Frankfurt to its primary customer, Celanese Corporation.
Why it mattersThe sale allows management to streamline post-Heubach operations, eliminate a non-core tolling business, and re-focus capital and management bandwidth strictly on core colorants and pigments.
Deal consideration: not disclosedGlobal manufacturing & R&D sites: 20Total employees: more than 3,900Countries served: over 120
📅 Short termSignals proactive portfolio cleanup post-Heubach takeover; near-term stock reaction may be tempered until cash inflows or balance sheet impact are quantified.
📈 Long termSupports strategic focus on high-margin specialty pigments and realization of targeted EUR 90-100 million integration EBITDA synergies without disrupting raw material supply.
⚠ Risk flags
- Financial consideration and transaction value not disclosed in the filing
- Ongoing dependency on Nutrinova for captive intermediate materials post-divestment
Key Highlights
Divestment of step-down subsidiary VP4 Frankfurt GmbH to Celanese Corporation
Asset was originally acquired as part of the Heubach Group acquisition
Primary output is Diketene used for functional food ingredients by Nutrinova
Transaction consideration and financial deal size were not disclosed
Nutrinova agreed to continue supplying necessary intermediate materials to Sudarshan
👀 What to Watch
Track subsequent quarterly disclosures for cash proceeds and any accounting gain/loss on disposal, along with ongoing Heubach integration synergy milestones.
Sudarshan Chem to Sell Step-Down Subsidiary VP4 Frankfurt to Celanese for EUR 76.5 Million
Sudarshan Chemical's step-down subsidiary, Sudarshan Germany Horizons GmbH, has executed a definitive Share Purchase and Transfer Agreement to sell 100% of VP4 Frankfurt GmbH to Celanese US Holdings LLC for EUR 76.5 million. VP4 Frankfurt is a tolling operator manufacturing intermediates, contributing EUR 15.72 million (1.64% of FY26 consolidated revenue) and EUR 5.67 million to net worth. The divestment of this non-core asset yields substantial cash proceeds compared to its book value, sharpening group focus on core pigments and strengthening liquidity.
Confidence: HIGH
What changedSudarshan Germany Horizons has agreed to divest 100% stake in intermediate toll-manufacturing unit VP4 Frankfurt to Celanese for EUR 76.5m.
Why it mattersThe sale monetizes a non-core intermediate tolling asset at ~13.5x its book value (EUR 5.67m net worth), infusing significant liquidity into the group post-Heubach acquisition.
Sale Consideration: EUR 76,500,000FY26 Revenue Contribution: EUR 15,722,521Consolidated Revenue Share: 1.64%Net Worth Contribution: EUR 5,670,674Agreement Date: 31st August, 2026
📅 Short termPositive sentiment driver as the transaction brings an unexpected cash infusion of ~EUR 76.5m at attractive valuation multiples.
📈 Long termEnhances capital efficiency and operational focus on the core global pigment integration following the Heubach acquisition.
⚠ Risk flags
- Subject to customary closing conditions and condition precedents before cash receipt
Key Highlights
100% stake in step-down subsidiary VP4 Frankfurt GmbH sold for a total consideration of EUR 76,500,000
Divested entity contributed EUR 15,722,521 in revenue (1.64% of consolidated revenue) as of March 31, 2026
Net worth contribution of VP4 Frankfurt was EUR 5,670,674 as of March 31, 2026
Acquiring party is Celanese US Holdings LLC, part of global chemical giant Celanese Corporation (non-related party)
Agreement signed on August 31, 2026; closing subject to customary conditions precedent
👀 What to Watch
Track the timeline to closing, receipt of the EUR 76.5 million cash consideration, and management commentary on capital allocation (e.g., debt reduction or integration funding for Heubach).
Sudarshan Chemical to Acquire Clariant's Muttenz Aluminium Dyes Plant in Switzerland
Sudarshan Chemical Industries, via its subsidiary Sudarshan Switzerland SLO AG, has signed a definitive Asset Sale and Transfer Agreement to acquire Clariant Additives' aluminium dyes manufacturing facility in Muttenz, Switzerland. The facility manufactures Sudarshan's Aluminium Dyes portfolio (brands including Sanodal®, Sanodure®, Sanodye®, and Anodal®), converting an expiring long-term supply contract into direct asset ownership. The deal secures proprietary multistep organic chemistry capabilities and workforce continuity, with completion expected around January 4, 2027. Transaction consideration was not disclosed in the press release.
Confidence: HIGH
What changedSudarshan transitioned from being a contract-manufacturing customer of Clariant's Muttenz plant to directly acquiring and owning the manufacturing assets and operational workforce.
Why it mattersSecures critical, high-barrier multi-step organic chemistry capacity for specialty aluminium dyes in-house, preventing supply disruption and enabling direct process control and future product innovation.
Expected Closing Date: 4 January 2027Transaction Value: not disclosedCompany TTM Revenue: ₹9,922 Cr
📅 Short termPositive sentiment from backward integration and securing proprietary supply chains, though financial impact will materialize post-closing in Q4 FY27.
📈 Long termEnhances Sudarshan's high-margin specialty dyes portfolio and strengthens European manufacturing presence alongside its broader global integration strategy.
⚠ Risk flags
- Acquisition cost and capex commitments are not disclosed
- Operating high-cost European manufacturing assets entails potential wage and energy cost inflation
- Closing remains subject to customary conditions precedent
Key Highlights
Definitive agreement signed to acquire Clariant's Muttenz (Switzerland) manufacturing plant for aluminium dyes and chemicals.
Acquisition secures core brands including Sanodal®, Sanodure®, Sanodye®, and Anodal® used in automotive, consumer electronics, and packaging.
Transaction closing expected on or around 4 January 2027 subject to customary conditions precedent.
Deal consideration and financial outlay were not disclosed in the filing.
👀 What to Watch
Track subsequent disclosures for the financial consideration, funding structure (debt vs cash), and margin accretion profile of the Muttenz plant ahead of the January 4, 2027 closing.
Sudarshan Chem Subsidiary to Acquire Clariant's Swiss Dyes Plant for CHF 7 Mn
Sudarshan Chemical's step-down wholly owned subsidiary, Sudarshan Switzerland SLO AG, has signed a definitive Asset Sale and Transfer Agreement to acquire Clariant Additives' manufacturing plant in Muttenz, Switzerland. The transaction involves a base consideration of CHF 7,000,000 (CHF 7 million) plus inventory value. The Muttenz facility has historically manufactured Sudarshan's Aluminium Dyes portfolio, including key brands like Sanodal®, Sanodure®, Sanodye®, and Anodal®. This strategic acquisition transitions a long-standing contract manufacturing relationship into direct asset ownership.
Confidence: HIGH
What changedSudarshan's Swiss subsidiary agreed to acquire Clariant's Muttenz aluminium dyes and chemicals plant, converting a third-party supply setup into full ownership.
Why it mattersSecures essential manufacturing infrastructure for key specialty dye brands, enhancing supply chain control and operational integration across global operations.
Base Purchase Consideration: CHF 7,000,000Agreement Execution Date: 24th August, 2026Inventory Consideration: determined in accordance with Agreement
📅 Short termNeutral to slightly positive; procedural steps and asset transfer approvals will proceed over coming months.
📈 Long termStrengthens specialty pigment manufacturing and vertical integration, supporting group margin expansion targets.
⚠ Risk flags
- Subject to fulfillment of conditions precedent before final asset handover
- Operating cost structures associated with European manufacturing facilities
Key Highlights
Definitive Asset Sale and Transfer Agreement executed on 24th August, 2026 with Clariant Additives (Switzerland) AG.
Base consideration fixed at CHF 7,000,000 (seven million Swiss Francs) plus inventory value.
Brings direct ownership of the Muttenz facility manufacturing Sanodal®, Sanodure®, Sanodye®, and Anodal® dye brands.
Assets cater to specialized anodized aluminium colorants used in automotive, consumer electronics, and packaging.
👀 What to Watch
Track the timeline for fulfilment of conditions precedent, transaction closing, and subsequent margin contributions from specialty aluminium dyes.
Sudarshan Chemical Q1 Revenue at ₹2,642 Cr; Net Debt Cut to ₹531 Cr from ₹922 Cr Peak
Sudarshan Chemical released its Q1 FY2027 earnings transcript highlighting strong integration progress following the global pigment acquisitions. Consolidated revenue rose 5% YoY to ₹2,642 Cr, while reported EBITDA increased by over 60% YoY to ₹266 Cr with quarterly EPS at ₹12.3. Net debt has been substantially reduced from a peak of ₹922 Cr down to ₹531 Cr, bringing the debt-to-equity ratio down to 0.2x. Management retained its guidance for the acquired business at EUR 700 million turnover and EUR 35 million EBITDA despite global logistics delays.
Confidence: HIGH
What changedFormal release of earnings call transcript detailing post-acquisition integration milestones and Q1 financial performance.
Why it mattersDemonstrates successful operational turnaround and margin recovery in the acquired international assets alongside continuous balance sheet deleveraging.
Q1 Revenue: Rs.2642 CroresQ1 Reported EBITDA: Rs.266 CroresCurrent Net Debt: Rs.531 CroresPeak Net Debt: Rs.922 CroresAcquired Group EBITDA Guidance: EUR 35 million
📅 Short termReflects steady operational execution, though management flagged shipping cycle extensions by two weeks due to Middle East disruptions.
📈 Long termConsolidation of 19 global manufacturing plants and cost synergies structurally solidify Sudarshan's position as the world's second-largest pigment player.
⚠ Risk flags
- Geopolitical and logistics disruptions extending shipping transit times by two weeks
- Temporary customer delays and site execution headwinds in the RIECO engineering segment (Q1 revenue ₹38 Cr)
Key Highlights
Consolidated revenue from operations stood at ₹2,642 Cr with reported EBITDA of ₹266 Cr (up >60% YoY)
Acquired group operations delivered ₹146 Cr in reported EBITDA (₹128 Cr business EBITDA)
Net debt reduced significantly to ₹531 Cr from a peak of ₹922 Cr, lowering D/E to 0.2x
Reported un-annualized Q1 EPS at ₹12.3 per share with annualized ROCE at 22.7%
Reiterated full-year acquired group guidance of EUR 700 million in revenue and EUR 35 million in EBITDA
👀 What to Watch
Track the execution of 'Project Integra' (One SAP implementation) and working capital cash release in the upcoming quarters.
Rs 2,642 Cr Q1 Revenue: Sudarshan Chemicals Reports 61% EBITDA Growth and Debt Reduction
Sudarshan Chemical reported a consolidated revenue of Rs 2,642 Cr for Q1 FY27, a 5.4% YoY increase, primarily driven by the integration of the Heubach Group. Reported EBITDA surged 61.4% YoY to Rs 266 Cr, reflecting a significant turnaround in the acquired business which saw its EBITDA grow 88% YoY to Rs 146 Cr. Net debt has been aggressively reduced to Rs 531 Cr from a peak of Rs 922 Cr in September 2025. The company reaffirmed its long-term FY29 revenue target of Rs 12,000-14,000 Cr.
Confidence: HIGH
What changedThe company has successfully transitioned into 'One Sudarshan' post-Heubach acquisition, showing immediate EBITDA improvement and significant deleveraging.
Why it mattersAs the world's 2nd largest pigment player, the successful turnaround of acquired global assets is critical for Sudarshan to scale its margins from the current 6% OPM toward its long-term targets.
Q1 Consolidated Revenue: Rs 2,642 CrQ1 Reported EBITDA: Rs 266 CrNet Debt: Rs 531 CrNet Debt vs Net Worth: ~21%FY29 Revenue Target: Rs 12,000-14,000 Cr
📅 Short termThe strong EBITDA growth and debt reduction are likely to be viewed positively by the market in the coming weeks as integration risks appear to be receding.
📈 Long termThe company is undergoing a structural transformation into a global leader; achieving the FY29 EBITDA target of Rs 1,400 Cr+ would represent a significant re-rating opportunity.
⚠ Risk flags
- Geopolitical tensions in the Middle East impacting logistics and raw material costs
- Execution delays in the RIECO engineering subsidiary
- Integration risks associated with the global SAP rollout
Key Highlights
Consolidated EBITDA grew 61.4% YoY to Rs 266 Cr in Q1 FY27
Net debt reduced by 42% from its peak of Rs 922 Cr to Rs 531 Cr
Acquired Group (Heubach) reported a 67.7% YoY increase in reported EBITDA to Rs 146 Cr
Legacy Sudarshan business revenue grew 22.3% YoY to Rs 768 Cr
Long-term FY29 guidance targets revenue of Rs 12,000-14,000 Cr and EBITDA of Rs 1,400-1,500 Cr
👀 What to Watch
Monitor the execution of the 'One SAP' project and the realization of the EUR 90-100 million EBITD value capture funnel. Investors should also track the recovery of the RIECO engineering segment, which reported a loss of Rs 10 Cr this quarter.
70.26% Stake in Sudarshan Colorants to be Acquired Directly; Q1 Standalone PAT at ₹57.8 Cr
Sudarshan Chemical's board has approved an internal restructuring to acquire a 70.26% direct stake in its step-down subsidiary, Sudarshan Colorants India Limited (formerly Heubach Colorants). The target entity is a significant contributor, reporting FY26 revenue of ₹807.5 Cr and PAT of ₹44.5 Cr. Simultaneously, the company reported standalone Q1 FY27 revenue of ₹677.4 Cr, up 27.5% YoY but down 7.5% sequentially. The restructuring aims to simplify the corporate structure as the company integrates the global Heubach Group acquisition.
Confidence: HIGH
What changedThe company is shifting its 70.26% indirect ownership of Sudarshan Colorants India to a direct ownership model through an internal share purchase from its European and Swiss subsidiaries.
Why it mattersThis simplifies the group's corporate structure and streamlines financial reporting and cash flow management from a subsidiary that accounts for approximately 8.2% of the group's TTM revenue.
Stake to be acquired: 70.26%Target FY26 Revenue: ₹807.5 CrTarget Revenue vs TTM Revenue: ~8.2%Standalone Q1 Revenue: ₹677.4 CrStandalone Q1 PAT: ₹57.8 CrShares to be acquired: 1,62,16,847
📅 Short termThe market may focus on the sequential decline in standalone profits (₹57.8 Cr vs ₹120.4 Cr in Mar 2026), though the restructuring itself is value-neutral.
📈 Long termThe move is a step toward consolidating the global pigment business post-Heubach acquisition, aiming for a 13-14% margin target in the medium term.
⚠ Risk flags
- Related-party transaction
- Sequential earnings decline
- Integration risks of global manufacturing facilities
Key Highlights
Acquisition of 1,62,16,847 equity shares (70.26% stake) in Sudarshan Colorants India Limited from existing subsidiaries.
Target company Sudarshan Colorants reported FY26 total income of ₹807.5 Cr and a net worth of ₹565.1 Cr.
Standalone Q1 FY27 revenue reached ₹677.4 Cr, compared to ₹531.2 Cr in the same quarter last year.
Standalone Q1 FY27 PAT stood at ₹57.8 Cr, down from ₹73.3 Cr YoY and ₹120.4 Cr sequentially.
The transaction will be completed via cash consideration at an arm's length fair value.
👀 What to Watch
Monitor the final valuation of the internal stake transfer and the progress of the 'One Sudarshan' integration strategy following the global Heubach acquisition.
₹57.8 Cr Standalone PAT in Q1; Board Approves 70.26% Stake Acquisition in Subsidiary
Sudarshan Chemical reported a standalone PAT of ₹57.8 Cr for Q1 FY27, representing a 52% decline from the previous quarter's ₹120.4 Cr, though revenue grew 27.5% YoY to ₹677.4 Cr. The Board also granted in-principle approval for an internal restructuring to directly acquire a 70.26% stake in Sudarshan Colorants India Limited (formerly Heubach Colorants) from its overseas subsidiaries. This target entity is significant, with an FY26 total income of ₹807.5 Cr and a net worth of ₹565.1 Cr. The restructuring aims to simplify the group's holding structure without altering overall control or business operations.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and initiated an internal restructuring to move its 70.26% stake in Sudarshan Colorants India from indirect (via overseas subsidiaries) to direct ownership.
Why it mattersThe restructuring simplifies the corporate hierarchy and brings a major revenue-generating Indian subsidiary directly under the parent company, while the earnings show steady YoY revenue growth despite QoQ margin pressure.
Standalone Revenue (Q1 FY27): ₹677.4 CrStandalone PAT (Q1 FY27): ₹57.8 CrTarget Entity FY26 Revenue: ₹807.5 CrTarget Revenue vs TTM Group Revenue: ~8.25%Stake to be acquired: 70.26%
📅 Short termThe stock may see neutral to slightly cautious sentiment due to the sequential (QoQ) drop in PAT and the shift from forex gains to losses.
📈 Long termThe direct ownership of the Indian subsidiary and the ongoing integration of Heubach's 17 global facilities are structural moves to achieve the company's goal of becoming the world's 2nd largest pigment player.
⚠ Risk flags
- Foreign exchange volatility (₹5.7 Cr loss in Q1)
- Integration risks of the global Heubach acquisition
- Rising material costs (₹444.2 Cr in Q1)
Key Highlights
Standalone revenue for Q1 FY27 reached ₹677.4 Cr, up from ₹531.2 Cr in the same quarter last year.
Standalone PAT stood at ₹57.8 Cr, impacted by a foreign exchange loss of ₹5.7 Cr compared to a gain of ₹24.6 Cr in the previous quarter.
Board approved acquiring 1,62,16,847 equity shares (70.26%) of Sudarshan Colorants India Limited to hold the stake directly.
The target subsidiary, Sudarshan Colorants, reported a PAT of ₹44.5 Cr on a total income of ₹807.5 Cr for FY26.
Standalone expenses increased to ₹629.1 Cr, with cost of materials consumed rising to ₹444.2 Cr.
👀 What to Watch
Investors should monitor the consolidated results to gauge the full impact of the Heubach Group integration and watch for the realization of the EUR 90-100 million EBITDA synergy target.
₹5.00 Final Dividend: Sudarshan Chemical Sets Aug 11 Record Date and Details TDS Norms
Sudarshan Chemical Industries has issued a formal communication regarding the Tax Deduction at Source (TDS) for its recommended final dividend of ₹5.00 per share (250% of face value) for FY 2025-26. The record date to determine eligibility is fixed for August 11, 2026, with the dividend subject to approval at the AGM on August 18, 2026. Resident shareholders with a valid PAN will be subject to a 10% TDS, while those without a PAN or with an inoperative PAN will face a 20% deduction. The total estimated payout of approximately ₹35.7 Cr represents a high percentage of the FY26 PAT of ₹40 Cr.
Confidence: HIGH
What changedThe company has formalized the administrative process, record date, and tax withholding requirements for the FY25-26 final dividend previously recommended in May 2026.
Why it mattersThis is a routine but necessary procedural update for shareholders to receive their net dividend proceeds; the high payout ratio relative to FY26 PAT (approx 89%) indicates a strong commitment to returning capital despite lower annual profits.
Final Dividend per Share: ₹5.00Dividend Yield (at current price): 0.45%Record Date: August 11, 2026TDS Exemption Limit (Resident Individuals): ₹10,000Estimated Total Payout vs FY26 PAT: ~89%
📅 Short termThe stock is expected to trade ex-dividend around the record date of August 11, which typically leads to a minor price adjustment corresponding to the dividend amount.
📈 Long termLimited structural impact as this is a routine dividend distribution; however, the high payout ratio relative to recent earnings will be a point for long-term investors to monitor alongside the Heubach acquisition integration.
⚠ Risk flags
- Higher TDS (20%) for shareholders with inoperative PAN or missing Aadhaar linkage.
Key Highlights
Final dividend recommended at ₹5.00 per equity share of face value ₹2.00 (250%).
Record date for determining shareholder eligibility is Tuesday, August 11, 2026.
TDS of 10% applicable for resident shareholders with valid PAN; 20% for those without or with inoperative PAN.
No TDS for resident individuals if the total dividend paid during FY 2026-27 does not exceed ₹10,000.
Dividend payment to be completed on or before September 8, 2026, post-AGM approval.
👀 What to Watch
Shareholders should ensure their PAN is updated and linked with Aadhaar with their Depository Participant or RTA before August 11, 2026, to avoid a higher 20% tax deduction.
₹5.00 Final Dividend: Sudarshan Chemical Sets August 11 as Record Date for 250% Payout
Sudarshan Chemical Industries has fixed August 11, 2026, as the record date for a final dividend of ₹5.00 per share (250% of face value) for FY25-26. This follows a transformative year where consolidated revenue reached ₹9,787 Cr, largely driven by the integration of the Heubach Group. The dividend is subject to shareholder approval at the 75th Annual General Meeting (AGM) scheduled for August 18, 2026. If approved, the dividend will be paid by September 8, 2026.
Confidence: HIGH
What changedThe company has formalized the timeline for its annual dividend payout and the 75th Annual General Meeting following the conclusion of the 2025-26 financial year.
Why it mattersWhile the dividend yield is modest at approximately 0.47%, the announcement confirms the company's return to steady payouts following a volatile year of global acquisitions and integration.
Final Dividend: ₹5.00 per shareDividend % of Face Value: 250%Record Date: 11-Aug-2026FY26 Consolidated Revenue: ₹9,787 CrDividend Yield: 0.47%
📅 Short termThe stock is likely to trade ex-dividend around August 11, 2026, which may lead to a minor price adjustment equivalent to the dividend amount.
📈 Long termThe company's structural focus remains on the 'One Sudarshan' integration of Heubach's 17 facilities to capture a targeted EUR 90-100 million EBITD funnel.
⚠ Risk flags
- Dividend payout (₹5.00) exceeds TTM EPS (₹2.84), though supported by strong Q4 FY26 earnings of ₹10.01 per share.
Key Highlights
Final dividend of ₹5.00 per equity share of face value ₹2.00 (250%) recommended for FY25-26.
Record date for determining dividend eligibility is Tuesday, August 11, 2026.
75th Annual General Meeting (AGM) scheduled for August 18, 2026, at 4:00 p.m. IST.
Consolidated revenue for FY26 stood at ₹9,787 Cr with a consolidated EBITDA of ₹579 Cr.
Dividend payment to be completed on or before September 8, 2026, post-shareholder approval.
👀 What to Watch
Investors should ensure their bank details are updated with depositories before the August 11 record date and monitor the AGM for management commentary on the Heubach integration synergies.
₹5.00 Final Dividend and FY26 Annual Report; Revenue Reaches ₹9,787 Cr Post-Heubach
Sudarshan Chemical has scheduled its 75th AGM for August 18, 2026, and confirmed a final dividend of ₹5.00 per share (250% of face value). The FY26 Annual Report reveals a massive revenue scale-up to ₹9,787 Cr following the Heubach Group acquisition, making it the world's second-largest pigment player. However, consolidated EBITDA margins remain compressed at 5.9% due to integration and global market factors. The company now operates 19 manufacturing facilities across 11 countries, serving over 4,000 customers.
Confidence: HIGH
What changedFormalization of the 75th AGM schedule and release of the first full-year consolidated annual report post the Heubach acquisition.
Why it mattersIt confirms the dividend payout and provides the first comprehensive look at the operational scale and margin profile of the newly consolidated global entity.
Final Dividend: ₹5.00 per shareFY26 Consolidated Revenue: ₹9,787 CrFY26 EBITDA Margin: 5.9%Dividend Yield (at ₹1057): 0.47%Manufacturing Facilities: 19
📅 Short termThe stock may see minor activity around the dividend record date of August 11, 2026.
📈 Long termThe structural focus remains on margin expansion from the current 5.9% toward historical double-digit levels as synergies from the Heubach acquisition materialize.
⚠ Risk flags
- Integration risks of 17 global facilities
- High working capital requirements
- Global commodity price volatility
Key Highlights
Final dividend of ₹5.00 per equity share (250%) recommended for FY 2025-26.
Consolidated revenue for FY26 stood at ₹9,787 Cr, compared to ₹3,345 Cr in FY25.
Consolidated EBITDA reported at ₹579 Cr with a margin of 5.9% for the full year.
Record date for dividend eligibility is fixed as August 11, 2026.
The group now operates 19 manufacturing facilities across 11 countries post-acquisition.
👀 What to Watch
Monitor the AGM on August 18 for management updates on the 'One Sudarshan' integration and the progress toward the targeted EUR 90-100 million EBITDA synergy goal.
₹5.00 Final Dividend and 75th AGM Notice; FY26 Consolidated Revenue at ₹9,787 Cr
Sudarshan Chemical has scheduled its 75th Annual General Meeting for August 18, 2026, and confirmed a final dividend of ₹5.00 per share (250% of face value). The company reported a significant scale-up in FY26 with consolidated revenue reaching ₹9,787 Cr, following the integration of the Heubach Group. However, margins remain compressed with a consolidated EBITDA margin of 5.9% and an adjusted ROCE of 10.8%. The record date for dividend eligibility is set for August 11, 2026.
Confidence: HIGH
What changedFormalization of the 75th AGM schedule and confirmation of the dividend record date and payout timeline.
Why it mattersThis filing provides the first comprehensive annual look at the 'One Sudarshan' entity post-acquisition, confirming its position as the world's 2nd largest pigment player while highlighting the current margin pressures of the integrated business.
Final Dividend: ₹5.00 per shareFY26 Consolidated Revenue: ₹9,787 CrConsolidated EBITDA: ₹579 CrEBITDA Margin: 5.9%Adjusted ROCE: 10.8%Dividend Record Date: August 11, 2026
📅 Short termThe stock may see minor activity around the dividend record date of August 11, but the primary focus will be on the AGM discussions regarding synergy realization.
📈 Long termThe structural shift to becoming a global leader is complete; long-term value depends on successfully integrating 17 new facilities and improving the low current margins (5.9%) through specialty pigment growth.
⚠ Risk flags
- Integration risks of the global Heubach acquisition
- Low consolidated EBITDA margins (5.9%)
- High working capital requirements due to global inventory stocking
Key Highlights
Final dividend of ₹5.00 per equity share (250% of ₹2.00 face value) recommended for FY25-26.
Consolidated revenue for FY26 stood at ₹9,787 Cr, reflecting the global scale post-Heubach acquisition.
Consolidated EBITDA reported at ₹579 Cr with a margin of 5.9%.
Manufacturing footprint expanded to 19 facilities across 11 countries serving 4,000+ customers.
Record date for dividend payment is August 11, 2026, with payment by September 8, 2026.
👀 What to Watch
Monitor management commentary during the AGM on August 18 regarding the 'Value Capture Funnel' and the timeline for improving EBITDA margins from the current 5.9% toward the long-term target of 13-14%.
₹5.00 Final Dividend and FY26 Annual Report: Sudarshan Chemical Sets AGM for August 18
Sudarshan Chemical has scheduled its 75th AGM for August 18, 2026, and confirmed a final dividend of ₹5.00 per share (250% of face value). The FY26 Annual Report reveals a consolidated revenue of ₹9,787 Cr, reflecting the full-year impact of the Heubach Group acquisition. While revenue grew significantly from ₹3,345 Cr in FY25, the consolidated EBITDA margin stood at 5.9%. The company now operates a global footprint with 19 manufacturing facilities across 11 countries, serving over 4,000 customers.
Confidence: HIGH
What changedFormal notice of the 75th AGM and release of the first full-year Annual Report following the transformative Heubach Group acquisition.
Why it mattersConfirms the financial scale of the newly consolidated 'ONE Sudarshan' entity, which is now the world's 2nd largest pigment player, though margins currently remain compressed at 5.9%.
Final Dividend: ₹5.00 per shareFY26 Consolidated Revenue: ₹9,787 CrFY26 Consolidated EBITDA: ₹579 CrEBITDA Margin: 5.9%Dividend Yield: 0.47%Manufacturing Facilities: 19 units
📅 Short termThe stock may see minor activity around the August 11 record date for the ₹5.00 dividend.
📈 Long termThe structural story depends on successfully realizing the EUR 90-100 million EBITD synergy target from the Heubach integration and improving overall margins.
⚠ Risk flags
- Integration risks of the global Heubach acquisition
- Low consolidated EBITDA margins (5.9%)
- Volatility in global commodity prices and logistics
Key Highlights
Final dividend of ₹5.00 per equity share (250% of ₹2.00 face value) recommended for FY25-26.
Consolidated revenue for FY26 reached ₹9,787 Cr, a massive jump from ₹3,345 Cr in FY25 due to acquisition integration.
Consolidated EBITDA for the year was ₹579 Cr with an operating margin of 5.9%.
Global manufacturing footprint expanded to 19 facilities across 11 countries following the Heubach acquisition.
Record date for dividend eligibility is set for Tuesday, August 11, 2026.
👀 What to Watch
Monitor the AGM on August 18 for management commentary on the 'Value Capture Funnel' and the progress of integrating Heubach to reach the targeted 13-14% specialty pigment margins.
Chairman Rajesh Rathi Raises Stake in Sudarshan Chemical via ₹100 Cr Warrant Conversion
Mr. Rajesh Rathi, Chairman and Managing Director, has exercised 9,80,000 convertible warrants, resulting in a capital infusion of approximately ₹100 crore into the company. The conversion was executed at a price of ₹1,019.75 per share, which notably represented a 16% premium over the market price on the allotment date of June 10, 2026. This transaction has increased the promoter group's holding from 8.19% to 9.32%. This move follows the company's significant acquisition of the Heubach Group in March 2025, signaling strong leadership commitment to the expanded global entity.
Key Highlights
Conversion of 9,80,000 warrants into equity shares at ₹1,019.75 per share.
Total capital commitment of nearly ₹100 crore by the Promoter/MD.
Promoter group holding increased from 8.19% to 9.32%.
Conversion price executed at a 16% premium to the market price on June 10, 2026.
Reinforces promoter confidence following the Heubach Group acquisition in March 2025.
👀 What to Watch
Investors should view the promoter's decision to increase their stake at a premium as a strong bullish signal regarding the company's long-term growth prospects and the successful integration of the Heubach acquisition.
Sudarshan Chemical Opens 21,000 Sq Ft Second Global Head Office in Frankfurt, Germany
Sudarshan Chemical has inaugurated its second global headquarters in Frankfurt, Germany, a 21,000 sq ft facility designed to integrate operations following its March 2025 acquisition of the Heubach Group. The new office is strategically located 11 km from the company's production site at Industriepark Höchst to foster collaboration across unified global operations. This move solidifies the company's footprint in Europe, supporting its network of 19 manufacturing sites and 4,000+ global customers. The expansion signals a strong commitment to post-merger growth and global leadership in the pigment industry.
Key Highlights
Inaugurated a new 21,000 sq ft second global head office in Schwalbach am Taunus, near Frankfurt.
The move follows the significant acquisition of the Heubach Group completed in March 2025.
The facility is located just 11 km from the company's production site at Industriepark Höchst.
Sudarshan now operates across 120+ countries with 19 manufacturing sites and 3,900+ employees.
The office is leased under the German operating entity, Sudarshan Germany Horizons GmbH.
👀 What to Watch
Investors should view this as a positive indicator of successful post-merger integration and global scale-up. Monitor future earnings for operational synergies and margin improvements resulting from this unified global management structure.
